Anzeige
Mehr »
Login
Sonntag, 03.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CYRV | ISIN: VGG6S34K1052 | Ticker-Symbol: 9W5
Berlin
01.11.24
21:40 Uhr
0,505 Euro
+0,007
+1,41 %
Branche
Internet
Aktienmarkt
ASIEN
1-Jahres-Chart
ABITS GROUP INC Chart 1 Jahr
5-Tage-Chart
ABITS GROUP INC 5-Tage-Chart
GlobeNewswire (Europe)
233 Leser
Artikel bewerten:
(1)

Abits Group Inc Reports Unaudited Financial Results for the First Half of 2024

Hong Kong, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Abits Group Inc (NASDAQ: ABTS) is pleased to announce its half-year results for the period ended June 30, 2024.

In a period when production is sustained throughout the six months, revenue grew to $3.67 million comprising 61.5 bitcoins, compared to the previous period when construction of the mining center in Tennessee was in progress and there was no production.. After accounting for direct costs of revenue amounting to $2.68 million, primarily electricity costs of $1.1 million and depreciation of $1.27 million, the gross profit from the mining operation was $0.75 million.

The loss before tax of the group was $0.14 million after accounting for administrative and general overheads.his result compares favorably with the previous period when the loss was $3.5 million. Administrative and general overheads during the period almost doubled to 1.11 million compared to $0.7 million as new staff were added to support production on a 24/7 basis as well as an increase on maintenance and insurance costs now that the data center was fully operational.

In April, the Company further improved its water supply and since then, all production lines have been kept running. During the peak construction periods, a 100,000-gallon reservoir helps to subsidize any shortages from the water company during the day and is replenished at night when consumption is much lower. The hydro cooling method introduced with the new batch of machines helps to reduce noise and dust instead of the traditional air cooling by fans.

There is no substantial change in the Balance Sheet of the Group except that more Ant-miner machines were purchased for $0.86 million and a piece of property in Wisconsin acquired for $0.65 million in the period to June. Cash and cash balances dwindled to $0.4 million as of June 30, 2024.

With the halving of mining rewards in late in April, production output will be much lower for the rest of 2024. However, the Company will maintain a strict control of its costs and hopes to secure more hosting contracts to improve on its revenue.

For more information, please visit www.abitsgroup.com or email ir@abitgrp.com.

ABITS GROUP INC
CONSOLIDATED BALANCE SHEETS

As of
Note June 30, 2024
(Unaudited)
December 31, 2023
ASSETS
Current Assets
Cash and cash equivalents $396,583 $884,199
Other receivables and prepayments 3 370,801 774,345
Total current assets 767,384 1,658,544
Digital assets 4 1,546,184 1,194,157
Property, equipment and vehicles 5 9,888,446 9,465,567
Construction-in-progress - -
TOTAL ASSETS 12,202,014 12,318,268
LIABILITIES AND SHAREHOLDERS' EQUITY
Other payables and accruals $920,700 $1,005,608
Stockholders' Equity
Preferred stock, $0.001010 par value, authorized; 50,000,000 shares, 5,000,000 shares issued and outstanding as of June 30, 2024 and December,31 2023 $5,050 $5,050
Common stock, $0.001 par value, authorized: 50,000,000 shares. Issued and outstanding: 35,554,677 shares as of June 30, 2024 and December,31, 2023 35,554 35,554
Additional paid-in capital 89,290,193 89,290,193
Accumulated deficit (77,907,687) (77,893,723)
Accumulated other comprehensive income (141,796) (124,414)
Total Shareholders' Equity 11,281,314 11,312,660
Total Liabilities and Shareholders' Equity $12,202,014 $12,318,268

ABITS GROUP INC
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

Six Months Ended Six Months Ended
June 30, 2024 June 30, 2023
Revenue $3,669,627 $7,272
Direct costs of revenue (2,680,658) (14,666)
Other operating costs (241,103) (2,802,735)
Profit/(Loss) from operations 747,866 (2,810,129)
General and administrative expenses (1,104,234) (692,947)
Finance expenses (14,903) -
Fair Value changes for 2024 digital assets 357,308
Loss before tax (13,964) (3,503,076)
Income tax - -
Loss after tax (13,964) (3,503,076)
Foreign exchange adjustment (17,382) 45,292
Comprehensive loss for the period $(31,346) $(3,457,784)
Basic and diluted loss per ordinary share $(0.001) $(0.097)
Basic and diluted average number of ordinary shares outstanding 35,554,677 35,554,677

ABITS GROUP INC.
UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES TO STOCKHOLDERS' EQUITY

Preferred Shares Ordinary Shares Additional
paid-in
Accumulated Accumulated
other
comprehensive
Number Amount Number Amount capital deficit income Total
Balance, December 31, 2022 5,000,000 5,050 35,554,677 35,554 89,290,193 (65,308,474) (104,361) 23,917,962
Net loss for the year - - - - - (12,585,249) (20,053) (12,605,302)
Balance, December 31, 2023 5,000,000 5,050 35,554,677 35,554 89,290,193 (77,893,723) (124,414) 11,312,660
Net loss for the period (13,964) (17,382) (31,346)
Balance, June 30, 2024 5,000,000 5,050 35,554,677 35,554 89,290,193 (77,907,687) (141,796) 11,281,314

ABITS GROUP INC.

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the
Six Months Ended
For the
Six Months Ended
June 30, 2024 June 30, 2023
Net loss for the period $(13,964) $(3,503,076)
Adjustment to reconcile cash used in operating activities:
Depreciation of property, and equipment 1,274,028 2,817,256
Changes in operating assets and liabilities:
Account receivables - 53
Other receivables and prepayments 403,544 (1,101,604)
Other payables and accruals (84,909) (71,974)
Digital assets (352,026) 2,370,769
Fixed assets (1,696,907) (1,522,949)
Cash used in operating activities (470,234) (1,011,525)
Effect of exchange rates on cash and cash equivalents (17,382) 45,070
Net decrease in cash and cash equivalents (487,616) (966,455)
Cash and cash equivalents, beginning of period 884,199 2,505,286
Cash and cash equivalents, end of period $396,583 $1,538,831

© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.